Yorek M A, Spector A A, Ginsberg B H
J Neurochem. 1985 Nov;45(5):1590-5. doi: 10.1111/j.1471-4159.1985.tb07231.x.
Cultured human Y79 retinoblastoma cells bind [125I]iodoinsulin in a manner similar to that of other CNS and peripheral tissues. The only difference noted between the insulin binding properties of the Y79 cells and other CNS preparations is that insulin binding to Y79 cells is down-regulated by prolonged exposure of the cells to insulin. By contrast, studies with the various brain preparations indicate that the brain insulin receptor is not down-regulated by circulating levels of insulin. Insulin binding to Y79 cells exhibits negative cooperativity, has a pH optimum of 7.8, is responsive to cations, and gives a curvilinear Scatchard plot. Y79 cell insulin binding capacity is 26 fmol/100 micrograms of cell protein, corresponding to about 125,000 binding sites per cell. These findings are the first to report insulin binding in a human cell line of retinal origin. The characterization of the insulin binding in this cell line may facilitate an understanding of the relationship between insulin and its specific functions in the human retina.
培养的人Y79视网膜母细胞瘤细胞以与其他中枢神经系统和外周组织相似的方式结合[125I]碘胰岛素。Y79细胞与其他中枢神经系统制剂的胰岛素结合特性之间唯一的差异在于,细胞长时间暴露于胰岛素会下调胰岛素与Y79细胞的结合。相比之下,对各种脑制剂的研究表明,脑胰岛素受体不会因循环中的胰岛素水平而下调。胰岛素与Y79细胞的结合表现出负协同性,最适pH值为7.8,对阳离子有反应,并给出曲线形的Scatchard图。Y79细胞的胰岛素结合能力为26 fmol/100微克细胞蛋白,相当于每个细胞约125,000个结合位点。这些发现首次报道了视网膜来源的人类细胞系中的胰岛素结合。该细胞系中胰岛素结合的特性可能有助于理解胰岛素与其在人类视网膜中的特定功能之间的关系。